102207-93-2

Upstream product

• 70797-90-9 (2R,3R,4R,5R)-3,4-Bis-benzyloxy-2-methoxy-5-trityloxymethyl-tetrahydro-furan 
• 124648-93-7 (2S,3R,4R,5R)-3,4-Bis-benzyloxy-2-methoxy-5-trityloxymethyl-tetrahydro-furan 
• 532401-38-0 methyl 6-O-trityl-α,β-ribofuranoside 
• 532401-39-1 methyl 2,3-di-O-benzyl-α-D-ribofuranoside 
• 532-20-7 D-Ribose 
• 1824-96-0 methyl ribofuranoside 
• 70831-62-8 methyl 2,3-di-O-benzyl-β-D-ribofuranoside 

Downstream Products

• 101996-90-1 methyl 2,3-di-O-benzyl-5-C-<2-(5-methylfuryl)>-β-D-allo-pentofuranoside 
• 101996-90-1 methyl 2,3-di-O-benzyl-5-C-<2-(5-methylfuryl)>-α-L-talo-pentofuranoside 
• 1319725-93-3 C₃₀H₄₂O₄ 
• 1319726-00-5 C₃₀H₄₂O₅ 
• 1319726-01-6 C₃₀H₄₄O₅ 
• 1319726-03-8 C₃₀H₄₂O₄ 
• 1319726-04-9 C₃₃H₄₆O₄ 
• 1319726-02-7 C₃₇H₅₀O₅ 
• 1319726-05-0 C₃₇H₄₈O₄ 
• 1319725-92-2 C₄₃H₆₂O₄Si 
• 1319726-06-1 C₄₅H₆₆O₅Si 
• 1319726-07-2 C₅₂H₇₂O₅Si 
• 1319726-08-3 C₄₆H₅₈O₅ 

Relevant academic research and scientific papers

A [Pd]-mediated ω-alkynone cycloisomerization approach for the central tetrahydropyran unit and the synthesis of C(31)-C(48) fragment of aflastatin A

A concise assembly of the central tetrahydropyran unit of aflastatin A featuring a Pd-mediated alkynone cycloisomerization to provide a glycal and its subsequent stereoselective hydroboration to deliver the requisite stereochemistry at C(33) and C(34) cen

The new and efficient synthesis of a heptose moiety of spicamycin

The new and efficient synthesis of 7-O-acetyl-4-azido-2,3,6-tri-O-benzyl-4-deoxy-L-glycero-α-L-manno- heptopyranosyl acetate (5), a key intermediate for the synthesis of novel anti-cancer antibiotic, spicamycin (1), starting from D-ribose is described.

A convenient route to enantiomerically pure, conjugated dienes from sugar allyltin derivatives

The transformation of sugar allyltin derivatives into enantiomerically pure dienes (R*-CH=CH-CH=CH2) is presented. The internal double bond with the trans-configuration is formed regardless of the configuration of the starting sugar allyltin. Copyright (C) 2000 Elsevier Science Ltd.